Copyright © 1995 by the European Society of Cardiology.
© 1995 The European Society of Cardiology
Hormonal induction of an immediate–early gene response in myogenic cell lines—a paradigm for heart growth
Medical Policlinic, University of Bonn Germany
Correspondence: L. Neyses, MD, Medical Policlinic, University of Bonn. Wilhelmstraβe 35-37, D-53111 Bonn, Germany
Cardiac hypertrophy is characterized by growth of myocardial cells without proliferation. Many endo- paracrine stimuli such as angiotensin II, endothelin, aradrenergic agonists, and insulin have been shown to be able to induce cardiac hypertrophy either in vivo or in vitro. We have used the myoblast model of differentiation and proliferation to determine nuclear signal transduction mechanisms in muscle and (by analogy) cardiac growth. The first nuclear event known to occur when a growth stimulus acts upon a cell is induction of a family of immediate-early genes. Our group focused on the role of one of these genes, the early growth response gene-1 (Egr-1). We have shown that this gene is induced in isolated adult cardiac myocytes in the presence of endothelin. An anti-sense oligonucleotide complementary to the first six codons of the Egr-1 mRNA abolishes the stimulation of protein synthesis induced by endothelin. In the present study we further characterized paracrine growth stimuli in the myogenic cell line Sol8, which was used as a paradigm to further investigate mechanisms of paracrine growth induction. We demonstrated that a variety of candidate endo- paracrine stimuli for the induction of cardiac hypertrophy induced the Egr-1 messenger RNA in the myogenic cell line Sol8. Among these are endothelin, insulin, basic fibroblast growth factor, and platelet-derived growth factor BB (PDGE BB). We conclude: (1) In analogy to the myocardium, these growth factors act upon myoblasts. (2) This line appears to be a suitable model for the molecular characterization of Egr-1 target genes.
Key Words: Muscle growth • proliferation • differentiation • Egr-1 • emdothelin • insulin • platelet-derived growth factor • basic fibroblast growth factor • cardiac hypertrophy
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Castro-Chaves, R. Fontes-Carvalho, M. Pintalhao, P. Pimentel-Nunes, and A. F. Leite-Moreira Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart Exp Physiol, June 1, 2009; 94(6): 665 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Sucharov, K. Dockstader, and T. A. McKinsey YY1 Protects Cardiac Myocytes from Pathologic Hypertrophy by Interacting with HDAC5 Mol. Biol. Cell, October 1, 2008; 19(10): 4141 - 4153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Davis, J. B Pillai, M. Gupta, and M. P. Gupta Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of {alpha}-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1477 - H1490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Maceira, J. Joshi, S. K. Prasad, J. C. Moon, E. Perugini, I. Harding, M. N. Sheppard, P. A. Poole-Wilson, P. N. Hawkins, and D. J. Pennell Cardiovascular Magnetic Resonance in Cardiac Amyloidosis Circulation, January 18, 2005; 111(2): 186 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, H. Rayford, R. Shu, J. Zhuang, and B. D. Uhal Essential role for cathepsin D in bleomycin-induced apoptosis of alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L46 - L51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. Han, K. J. Austin, P. W. Nathanielsz, S. P. Ford, M. J. Nijland, and T. R. Hansen Maternal nutrient restriction alters gene expression in the ovine fetal heart J. Physiol., July 1, 2004; 558(1): 111 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.B.J. Burton, M.H. Yacoub, and P.J.R. Barton Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development Eur. Heart J., April 2, 1999; 20(8): 604 - 611. [Abstract] [PDF]
|
|